John joins CRF Health from Medtronic, Inc. Surgical Technologies where he served as Head of Global Services, overseeing the inception and development of Medtronic’s worldwide services business for surgical navigation and intra-operative imaging.

A twenty four year veteran of the Technology and Medical Device sectors, John has held leadership roles at several Global 500
companies. From product development through life cycle management; consultative selling; marketing to services and support, he
brings a customer centric approach to managing operations and setting strategy.

John served as Head of Global Services for Medtronic Surgical Technologies and was responsible for developing clinical, professional
and technical services, and supporting the corporation’s international expansion. This included a full integration of Medtronic’s
intellectual properties in surgical navigation and imaging into a sustainable value proposition to the market place.
Prior to his work at Medtronic, John gained practical business perspective with Philips Medical Systems (Vice President and General
Manager, Integrated Clinical Solutions), Agfa Healthcare (Vice President, Services and Support), StorageTek (Vice President, Global
Services), Toshiba Computer Systems (Vice President, Technical Services and Support), AT&T and NCR.

Rachael King, CEO commented, "We are delighted to have John Larson join CRF Health as its COO. John has a proven track record of delivering excellence and his complimentary experience in the Medical Device area will help broaden CRF Health’s offering. John’s
focus on "voice of the customer" integrates well with our continual improvement program."

John Larson added, "We are in a very dynamic time in the healthcare industry’s history and I am excited to be in a position to support
the introduction of new products and services. CRF Health is positioned to quickly and accurately support its pharmaceutical Sponsors in all phases of their clinical trials. As the global leader in ePRO technology, setting the trend in the elimination of paper trials will continue to be the mainstream focus. Our cutting edge solutions indirectly influence the global well-being of mankind allowing our Sponsors to bring new treatments to market through the application of robust ePRO standards."